EU drug regulator: Unusual blood clot ‘very rare AstraZeneca side effect’


The regulator said that one plausible explanation for the combination of blood clots and low blood platelets was an “immune response, leading to a condition similar to one seen sometimes in patients treated with heparin (heparin induced thrombocytopenia, HIT)”.

Source link